Atlas Trials

ADC-induced Neurotoxicity Treated With Duloxetine

Clinical trial NCT06551051 · RECRUITING

Trial details

NCT number
NCT06551051
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Solid Tumour
Start date
2024-08-06
Primary completion
2025-12-30
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.